Abstract
Lutein, a dietary antioxidant, can be a potent treatment for Alzheimer’s disease. In this study, the neuroprotective effect of lutein against scopolamine-induced learning and memory impairment was studied in zebrafish and mice. Lutein significantly ameliorated the effects of scopolamine on escape spatial learning and memory. Biochemical and histopathological investigation revealed that oral treatment of lutein shows neuroprotective effects in the pathogenesis of Alzheimer’s disease by regulating lipid peroxidation and reducing oxidative stress in the hippocampus of scopolamine-treated mice and zebrafish. These study results indicate that lutein possesses anti-amnesic property via acetylcholine esterase inhibition and regulation of lipid peroxidation in neuronal cell. Hence, lutein could be a potential compound to treat Alzheimer’s disease.
Graphical Abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barker FM, Snodderly DM, Johnson EJ, Schalch W, Koepcke W, Gerss J, Neuringer M (2011) Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest Ophthalmol vis Sci 52:3934–3942. https://doi.org/10.1167/iovs.10-5898
Barnhart CD, Yang D, Lein PJ (2015) Using the Morris water maze to assess spatial learning and memory in weanling mice. PLoS ONE 10:e0124521. https://doi.org/10.1371/journal.pone.0124521
Cognato GdP, Bortolotto JW, Blazina AR, Christoff RR, Lara DR, Vianna MR, Bonan CD (2012) Y-Maze memory task in zebrafish (Danio rerio): the role of glutamatergic and cholinergic systems on the acquisition and consolidation periods. Neurobiol Learn Mem 98:321–328. https://doi.org/10.1016/j.nlm.2012.09.008
Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12-20. https://doi.org/10.1093/hmg/ddq160
Das SK, Pal S, Ghosal MK (2012) Dementia: Indian scenario. Neurol India 60:618–624. https://doi.org/10.4103/0028-3886.105197
Ellman GL, Courtney KD, Andres VJ, Feather-stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95. https://doi.org/10.1016/0006-2952(61)90145-9
Erdman JWJ, Smith JW, Kuchan MJ, Mohn ES, Johnson EJ, Rubakhin SS, Wang L, Sweedler JV, Neuringer M (2015) Lutein and brain function. Foods 4:547–564. https://doi.org/10.3390/foods4040547
Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ (2012) Neuroprotective effect of natural products against Alzheimer’s disease. Neurochem Res 37:1829–1842. https://doi.org/10.1007/s11064-012-0799-9
Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer’s disease: targeting the cholinergic system. Curr Neuropharmacol 14:101–115. https://doi.org/10.2174/1570159x13666150716165726
Fuad NIN, Sekar M, Gan SH, Lum PT, Vaijanathappa J, Ravi S (2020) Lutein: a comprehensive review on its chemical, biological activities and therapeutic potentials. Pharmacogn J 12:1769–1778. https://doi.org/10.5530/pj.2020.12.239
Hardy J, Bogdanovic N, Winblad B, Portelius E, Andreasen N, Cedazo-Minguez A, Zetterberg H (2014) Pathways to Alzheimer’s disease. J Intern Med 275:296–303. https://doi.org/10.1111/joim.12192
Kim YH, Lee KS, Park AR, Min TJ (2017) Adding preferred color to a conventional reward method improves the memory of zebrafish in the T-maze behavior model. Anim Cells Syst 21:374–381. https://doi.org/10.1080/19768354.2017.1383938
Koushan K, Rusovici R, Li W, Ferguson LR, Chalam KV (2013) The role of lutein in eye-related disease. Nutrients 5:1823–1839. https://doi.org/10.3390/nu5051823
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478. https://doi.org/10.1016/0076-6879(90)86141-h
Mahmoud WR, Nissan YM, Elsawah MM, Refaey RH, Ragab MF, Amin KM (2019) Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives. Eur J Med Chem 182:111651. https://doi.org/10.1016/j.ejmech.2019.111651
Manuel R, Gorissen M, Roca CP, Zethof J, van de Vis H, Flik G, van den Bos R (2014) Inhibitory avoidance learning in zebrafish (Danio rerio): effects of shock intensity and unraveling differences in task performance. Zebrafish 11:341–352. https://doi.org/10.1089/zeb.2013.0970
Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78. https://doi.org/10.1016/0304-4165(79)90289-7
Murman DL (2015) The impact of age on cognition. Semin Hear 36:111–121. https://doi.org/10.1055/s-0035-1555115
OECD (2008) Test No. 425: Acute oral toxicity: up-and-down procedure. Up-and-Down Procedure, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris. https://doi.org/10.1787/9789264071049-en. Accessed 15 Oct 2019
OECD (2019) Test No. 203: Fish, acute toxicity test. OECD Guidelines for the Testing of Chemicals, Section 2, OECD Publishing, Paris. https://doi.org/10.1787/9789264069961-en. Accessed 15 Oct 2019
Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K (2012) Neuroprotective effects of lutein in the retina. Curr Pharm Des 18:51–56. https://doi.org/10.2174/138161212798919101
Patel C, Pande S, Acharya S (2020) Potentiation of anti-Alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn-Schmiedebergs Arch Pharmacol 393:1955–1962. https://doi.org/10.1007/s00210-020-01904-3
Saraf MK, Prabhakar S, Khanduja KL, Anand A (2011) Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice. Evid Based Complement Alternat Med 2011:236186. https://doi.org/10.1093/ecam/neq038
Shegokar R, Mitri K (2012) Carotenoid lutein: a promising candidate for pharmaceutical and nutraceutical applications. J Diet Suppl 9:183–210. https://doi.org/10.3109/19390211.2012.708716
Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G (2016) Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds. Oxid Med Cell Longev 2016:7361613. https://doi.org/10.1155/2016/7361613
Stringham JM, Johnson EJ, Hammond BR (2019) Lutein across the lifespan: from childhood cognitive performance to the aging eye and brain. Curr Dev Nutr 3:nzz066. https://doi.org/10.1093/cdn/nzz066
Vasconcelos B, Bird M, Stancu I, Terwel D, Dewachter I (2017) Preclinical models of Alzheime’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy. In: Baekelandt V, Lobbestael E (eds) Disease-modifying targets in neurodegenerative disorders. Academic Press, Cambridge, pp 115–156. https://doi.org/10.1016/B978-0-12-805120-7.00006-3
Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ (2013) Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 16:21–29. https://doi.org/10.1179/1476830512Y.0000000024
Weydert CJ, Cullen JJ (2010) Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 5:51–66. https://doi.org/10.1038/nprot.2009.197
Xian Y-F, Lin Z-X, Zhao M, Mao Q-Q, Ip S-P, Che C-T (2011) Uncaria rhynchophylla ameliorates cognitive deficits induced by D-galactose in mice. Planta Med 77:1977–1983. https://doi.org/10.1055/s-0031-1280125
Zhang C, Bruins ME, Yang Z-Q, Liu S-T, Rao P-F (2016) A new formula to calculate activity of superoxide dismutase in indirect assays. Anal Biochem 503:65–67. https://doi.org/10.1016/j.ab.2016.03.014
Acknowledgements
The author would like to thank JRF (Jai Research Foundation), Valvada, Gujarat.
Author information
Authors and Affiliations
Contributions
Conceptualization: CP, PP; methodology: PP, DS; formal analysis and investigation: CP, PP, DS; writing original draft preparation: PP, JB, AS, KI; writing review and editing: CP, KI, SA; supervision: CP, SA.
Corresponding author
Ethics declarations
Ethics Approval
All animal experiments were conducted in accordance with the procedure approved by the Institutional Animal Ethics Committee (SSR/IAEC/2018/03). All the international standards and the ethical guidelines on animal welfare were strictly followed throughout the experimentation.
Conflict of Interest
The authors declare no competing interests.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Patel, C., Patel, P., Sarkar, D. et al. Neuroprotective Effect of Lutein in Scopolamine-Induced Alzheimer’s Disease in Mice and Zebrafish. Rev. Bras. Farmacogn. 31, 762–771 (2021). https://doi.org/10.1007/s43450-021-00202-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-021-00202-0